한글목차

뇌종양 치료제 동향 및 전망

세계 뇌종양 치료제 시장은 2024년부터 2030년까지 8.7%의 연평균 복합 성장률(CAGR)로 성장할 것으로 예상됩니다. 이 시장의 주요 촉진요인은 흡연율 증가, 고령화 인구 증가, 스트레스 및 전자파 노출입니다. 세계 뇌종양 치료제 시장은 병원 약국 및 소매 및 온라인 약국 시장에서 기회가 있고 미래가 유망합니다.

부문별 뇌종양 치료제

이 조사에는 전 세계 뇌종양 치료제의 치료법별, 적응증별, 유통 채널별, 지역별 예측이 포함되어 있습니다.

뇌종양 치료제 시장 인사이트

Lucintel의 예측에 따르면, 뇌종양 치료에 사용되는 보조요법인 화학요법은 예측 기간 동안 가장 큰 부문을 차지할 것으로 보입니다.

뇌종양을 치료하기 위한 약물이 처방되고 병원 내 투여가 필요하기 때문에 병원 약국이 이 시장에서 큰 비중을 차지할 것으로 보입니다.

북미는 유리한 상환 정책과 신약 출시 증가로 인해 예측 기간 동안 가장 규모가 큰 지역으로 남을 것으로 보입니다.

자주 묻는 질문

Q1. 시장 성장 예측은 다음과 같습니다.

A1. 세계 뇌종양 치료제 시장은 2024년부터 2030년까지 연평균 8.7%의 성장률을 보일 것으로 예상됩니다.

Q2. 시장 성장에 영향을 미치는 주요 촉진요인은 다음과 같습니다.

A2.이 시장의 주요 촉진요인은 흡연율 증가, 고령화 인구 증가, 스트레스 및 전자파 노출입니다.

Q3. 시장의 주요 부문은 다음과 같습니다.

A3. 뇌종양 치료제 시장의 미래는 병원 약국 시장, 소매 및 온라인 약국 시장에서 기회가 있고 유망합니다.

Q4. 시장 주요 기업은 다음과 같습니다.

A4. 뇌종양 치료제 주요 기업은 다음과 같습니다.

• Hoffmann-La Roche
• Pfizer
• Novartis
• Amgen
• Merck & Co

Q5. 향후 가장 큰 시장 부문은 다음과 같습니다.

A5. Lucintel은 뇌종양 치료에 사용되는 보조요법인 화학요법이 예측 기간 동안 가장 큰 부문을 차지할 것으로 예상하고 있습니다.

Q6. 시장에서 향후 5년간 가장 큰 시장이 될 것으로 예상되는 지역은 어디입니까?

A6. 북미는 유리한 상환 정책과 신약 출시 증가로 인해 예측 기간 동안 가장 규모가 큰 지역입니다.

Q7. 보고서 사용자 정의가 가능합니까?

A7. 네. Lucintel은 추가 비용없이 10%의 사용자 정의를 제공합니다.

목차

제1장 주요 요약

제2장 세계의 뇌종양 치료제 시장 : 시장 역학

• 서론, 배경, 분류
• 공급망
• 업계 촉진요인과 과제

제3장 시장 동향과 예측 분석(2018-2030년)

• 거시경제 동향(2018-2023년)과 예측(2024-2030년)
• 세계의 뇌종양 치료제 시장 동향(2018-2023년)과 예측(2024-2030년)
• 세계의 뇌종양 치료제 시장 : 요법 별
  • 표적치료
  • 화학요법
  • 면역치료
  • 기타
• 세계의 뇌종양 치료제 시장 : 적응증별
  • 뇌하수체
  • 수막종
  • 신경교종
  • 기타
• 세계의 뇌종양 치료제 시장 : 유통 채널별
  • 병원 약국
  • 소매 및 온라인 약국

제4장 지역별 시장 동향과 예측 분석(2018-2023년)

• 지역별 세계의 뇌종양 치료제 시장
• 북미의 뇌종양 치료제 시장
• 유럽의 뇌종양 치료제 시장
• 아시아태평양의 뇌종양 치료제 시장
• 기타 지역의 뇌종양 치료제 시장

제5장 경쟁 분석

• 제품 포트폴리오 분석
• 운영 통합
• Porter의 Five Forces 분석

제6장 성장 기회와 전략 분석

• 성장 기회 분석
• 세계 뇌종양 치료제 시장의 새로운 동향
• 전략 분석
  • 신제품 개발
  • 세계의 뇌종양 치료제 시장 능력 확대
  • 세계 뇌종양 치료제 시장에서의 인수합병(M&A) 및 합작투자(JV)
  • 인증과 라이선싱

제7장 주요 기업 개요

• Hoffmann-La Roche
• Pfizer
• Novartis
• Amgen
• Merck & Co

영문목차

Brain Tumor Drug Trends and Forecast

The future of the global brain tumor drug market looks promising with opportunities in the hospital pharmacy and retail & online pharmacy markets. The global brain tumor drug market is expected to grow with a CAGR of 8.7% from 2024 to 2030. The major drivers for this market are rising prevalence of smoking, increasing aging population, and stress and exposure to electromagnetic radiation.

A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.

Brain Tumor Drug by Segment

The study includes a forecast for the global brain tumor drug by therapy, indication, distribution channel, and region.

Brain Tumor Drug Market by Therapy [Shipment Analysis by Value from 2018 to 2030]:

• Targeted Therapy
• Chemotherapy
• Immunotherapy
• Others

Brain Tumor Drug Market by Indication [Shipment Analysis by Value from 2018 to 2030]:

• Pituitary
• Meningioma
• Glioma
• Others

Brain Tumor Drug Market by Distribution Channel [Shipment Analysis by Value from 2018 to 2030]:

• Hospital Pharmacy
• Retail & Online Pharmacy

Brain Tumor Drug Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Brain Tumor Drug Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies brain tumor drug companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the brain tumor drug companies profiled in this report include-

• Hoffmann-La Roche
• Pfizer
• Novartis
• Amgen
• Merck & Co

Brain Tumor Drug Market Insights

Lucintel forecasts that chemotherapy will remain the largest segment over the forecast period as it is adjuvant therapy, which is employed for the treatment of brain tumors.

Within this market, hospital pharmacy will remain larger segment as drugs designed to treat the condition are prescribed and necessitate administration within hospital settings.

North America will remain the largest region over the forecast period due to favorable reimbursement policies and rising launch of new drugs in the market.

Features of the Global Brain Tumor Drug Market

Market Size Estimates: Brain tumor drug market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Brain tumor drug market size by therapy, indication, distribution channel, and region in terms of value ($B).

Regional Analysis: Brain tumor drug market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different therapy, indication, distribution channels, and regions for the brain tumor drug market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the brain tumor drug market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the growth forecast for brain tumor drug market?

Answer: The global brain tumor drug market is expected to grow with a CAGR of 8.7% from 2024 to 2030.

Q2. What are the major drivers influencing the growth of the brain tumor drug market?

Answer: The major drivers for this market are rising prevalence of smoking, increasing aging population and stress and exposure to electromagnetic radiation.

Q3. What are the major segments for brain tumor drug market?

Answer: The future of the brain tumor drug market looks promising with opportunities in the hospital pharmacy and retail & online pharmacy markets.

Q4. Who are the key brain tumor drug market companies?

Answer: Some of the key brain tumor drug companies are as follows:

• Hoffmann-La Roche
• Pfizer
• Novartis
• Amgen
• Merck & Co

Q5. Which brain tumor drug market segment will be the largest in future?

Answer: Lucintel forecasts that chemotherapy will remain the largest segment over the forecast period as it is adjuvant therapy, which is employed for the treatment of brain tumors.

Q6. In brain tumor drug market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to favorable reimbursement policies and rising launch of new drugs in the market.

Q.7 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the brain tumor drug market by therapy (targeted therapy, chemotherapy, immunotherapy, and others), indication (pituitary, meningioma, glioma, and others), distribution channel (hospital pharmacy and retail & online pharmacy), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Brain Tumor Drug Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global Brain Tumor Drug Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global Brain Tumor Drug Market by Therapy
  • 3.3.1: Targeted Therapy
  • 3.3.2: Chemotherapy
  • 3.3.3: Immunotherapy
  • 3.3.4: Others
• 3.4: Global Brain Tumor Drug Market by Indication
  • 3.4.1: Pituitary
  • 3.4.2: Meningioma
  • 3.4.3: Glioma
  • 3.4.4: Others
• 3.5: Global Brain Tumor Drug Market by Distribution Channel
  • 3.5.1: Hospital Pharmacy
  • 3.5.2: Retail & Online Pharmacy

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global Brain Tumor Drug Market by Region
• 4.2: North American Brain Tumor Drug Market
  • 4.2.1: North American Brain Tumor Drug Market by Therapy: Targeted Therapy, Chemotherapy, Immunotherapy, and Others
  • 4.2.2: North American Brain Tumor Drug Market by Distribution Channel: Hospital Pharmacy and Retail & Online Pharmacy
• 4.3: European Brain Tumor Drug Market
  • 4.3.1: European Brain Tumor Drug Market by Therapy: Targeted Therapy, Chemotherapy, Immunotherapy, and Others
  • 4.3.2: European Brain Tumor Drug Market by Distribution Channel: Hospital Pharmacy and Retail & Online Pharmacy
• 4.4: APAC Brain Tumor Drug Market
  • 4.4.1: APAC Brain Tumor Drug Market by Therapy: Targeted Therapy, Chemotherapy, Immunotherapy, and Others
  • 4.4.2: APAC Brain Tumor Drug Market by Distribution Channel: Hospital Pharmacy and Retail & Online Pharmacy
• 4.5: ROW Brain Tumor Drug Market
  • 4.5.1: ROW Brain Tumor Drug Market by Therapy: Targeted Therapy, Chemotherapy, Immunotherapy, and Others
  • 4.5.2: ROW Brain Tumor Drug Market by Distribution Channel: Hospital Pharmacy and Retail & Online Pharmacy

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Brain Tumor Drug Market by Therapy
  • 6.1.2: Growth Opportunities for the Global Brain Tumor Drug Market by Indication
  • 6.1.3: Growth Opportunities for the Global Brain Tumor Drug Market by Distribution Channel
  • 6.1.4: Growth Opportunities for the Global Brain Tumor Drug Market by Region
• 6.2: Emerging Trends in the Global Brain Tumor Drug Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Brain Tumor Drug Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Brain Tumor Drug Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Hoffmann-La Roche
• 7.2: Pfizer
• 7.3: Novartis
• 7.4: Amgen
• 7.5: Merck & Co